Your browser doesn't support javascript.
loading
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi, Mária; Priksz, Dániel; Fülöp, Gábor Áron; Bódi, Beáta; Gyöngyösi, Alexandra; Nagy, Lilla; Kovács, Árpád; Kertész, Attila Béla; Kocsis, Judit; Édes, István; Csanádi, Zoltán; Czuriga, István; Kisvárday, Zoltán; Juhász, Béla; Lekli, István; Bai, Péter; Tóth, Attila; Papp, Zoltán; Czuriga, Dániel.
Afiliação
  • Lódi M; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Priksz D; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Fülöp GÁ; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Bódi B; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Gyöngyösi A; Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
  • Nagy L; MTA-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary.
  • Kovács Á; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Kertész AB; Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, H-4032, Debrecen, Hungary.
  • Kocsis J; Department of 3rd Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Édes I; Oncoradiology Center, Bács-Kiskun County Hospital, Kecskemét, Hungary.
  • Csanádi Z; Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, H-4032, Debrecen, Hungary.
  • Czuriga I; Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, H-4032, Debrecen, Hungary.
  • Kisvárday Z; Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, H-4032, Debrecen, Hungary.
  • Juhász B; Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Lekli I; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Bai P; Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
  • Tóth A; MTA-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary.
  • Papp Z; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Czuriga D; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
J Transl Med ; 17(1): 229, 2019 07 19.
Article em En | MEDLINE | ID: mdl-31324258
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article